REFERENCES
- Schreiber G B, Busch M P, Kleinman S H, Korelitz JJ. The risk of transfusion-transmitted viral infections. N Engl J Med 1996; 334: 1685–1690
- Hirayama J, Wagner S J, Gomez C, MacDonald V W, Abe H, Ikeda H, Ikebuchi K, Sekiguchi S. Virus photoinactivation in stroma-free hemoglobin with methylene blue or 1,9-dimethylemethylene blue. Photochem Photobiol 2000; 71: 90–93
- Abe H, Sugawar H, Hirayama J, Ihara H, Kato K, Ikeda H, Ikebuchi K. Removal of parvovirus B19 from hemoglobin solution by nanofiltration. Artif Cells Blood Substit Immobil Biotechnol 2000; 28: 375–383
- Azari M, Ebeling A, Baker R, Burhop K, Camacho T, Estep T, Guzder S, Marshall T, Rohn K, Sarajari R. Validation of the heat treatment step used in the production of diaspirin crosslinked hemoglobin (DCLHb™) for viral inactivation. Artif Cells Blood Substit Immobil Biotechnol 1998; 25: 577–582
- Takeoka S, Sakai H, Terase K, Nishide H, Tsuchida E. Characteristics of Hb-vesicles and encapsulation procedure. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 861–866
- Sakai H, Hamada K, Takeoka S, Nishide H, Tsuchida E. Physical properties of hemoglobin vesicles as red cell substitutes. Biotechnol Prog 1996; 12: 119–125
- Sakai H, Tomiyama K I, Sou K, Takeoka S, Tsuchida E. Poly(ethylene glycol)-conjugation and deoxygenation enable long-term preservation of hemoglobin-vesicles as oxygen carriers in a liquid state. Bioconjug Chem 2000; 11: 425–432
- Sakai H, Takeoka S, Nishide H, Tsuchida E. Convenient method to purify hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 1994; 22: 651–656
- Hirayama J, Abe H, Ikebuchi K, Horiuchi M, Shinagawa M, Kamo N, Sekiguchi S. Virus inactivation in superoxide dismutase preparations by ultra-violet light irradiation. Biol Pharm Bull 1998; 21: 621–623
- Reed L J, Müench H. A simple method of estimating 50 percent endpoints. Am J Hyg 1938; 27: 493–497
- van Kampen E J, Zijlstra W G. Determination of hemoglobin and its derivatives. Adv Clin Chem 1965; 8: 141–187